Literature DB >> 26052724

Chitosan nanoparticles as adenosine carriers.

Mehdi Kazemzadeh-Narbat1, Marla Reid, Marianne Su-Ling Brooks, Amyl Ghanem.   

Abstract

The objective of this research project was to evaluate the potential use of chitosan (CS) nanoparticles (NPs) as a drug delivery system for the molecule adenosine. Adenosine is an essential drug used for treating several health issues especially irregular heart rhythm. However, due to its extremely short half-life in vivo (<10 s), the effective delivery of adenosine in clinical applications is a significant challenge. In this research, adenosine was encapsulated into NPs formed by ionic gelation of CS. The encapsulation efficiency and loading capacity of 20% and 3% were obtained, respectively, by forming a complex between CS NPs and adenosine. The obtained CS NPs had a spherical shape in the size range of 260.6 ± 20.1 nm. Spectrophotometry analysis of the adenosine released in vitro showed an initial burst release phase, a plateau phase, followed by a steady release over a week.

Entities:  

Keywords:  Adenosine; chitosan; drug delivery systems; nanoparticles

Mesh:

Substances:

Year:  2015        PMID: 26052724     DOI: 10.3109/02652048.2015.1046517

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  3 in total

Review 1.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

2.  Biological Safety and Biodistribution of Chitosan Nanoparticles.

Authors:  Dmitry Sonin; Evgeniia Pochkaeva; Sergei Zhuravskii; Viktor Postnov; Dmitry Korolev; Lyubov Vasina; Daria Kostina; Daria Mukhametdinova; Irina Zelinskaya; Yury Skorik; Elena Naumysheva; Anna Malashicheva; Pavel Somov; Maria Istomina; Natalia Rubanova; Ilia Aleksandrov; Marina Vasyutina; Michael Galagudza
Journal:  Nanomaterials (Basel)       Date:  2020-04-23       Impact factor: 5.076

3.  Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.

Authors:  Jianjun Yu; Wei Li; Dongmei Yu
Journal:  Drug Des Devel Ther       Date:  2018-06-11       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.